1255734554 OPTIQUS VISION, INC.

Point of Service

Active

Basic Information

Organization Name
OPTIQUS VISION, INC.
Enumeration Date
September 30, 2014
Last Update
September 30, 2014
Authorized Official
GLENDA DAMARIS SANTINI OD
OPTOMETRA
Phone: (787) 238-0111

Practice Location

Address
1 CALLE ACUARELA STE 103
GUAYNABO, PR 009693591
Phone
(787) 272-7777
Fax
(787) 272-7777

Mailing Address

Address
1 CALLE ACUARELA STE 103
GUAYNABO, PR 009693591
Phone
(787) 272-7777
Fax
(787) 272-7777

Specialties & Taxonomies

Specialty Code Classification License State Primary
Point of Service
305S00000X Point of Service 448 PR Primary

Frequently Asked Questions

What is OPTIQUS VISION, INC.'s NPI number?
OPTIQUS VISION, INC.'s NPI number is 1255734554.
Which doctor has NPI number 1255734554?
The doctor with NPI number 1255734554 is OPTIQUS VISION, INC..
What is OPTIQUS VISION, INC.'s practice address?
OPTIQUS VISION, INC.'s practice address is 1 CALLE ACUARELA STE 103, GUAYNABO, PR, 009693591.
Which doctor practices at 1 CALLE ACUARELA STE 103, GUAYNABO, PR, 009693591?
OPTIQUS VISION, INC. practices at 1 CALLE ACUARELA STE 103, GUAYNABO, PR, 009693591.
What is OPTIQUS VISION, INC.'s phone number?
OPTIQUS VISION, INC.'s phone number is (787) 272-7777.
Who is (787) 272-7777?
(787) 272-7777 is the phone number for OPTIQUS VISION, INC..
What is OPTIQUS VISION, INC.'s specialty?
OPTIQUS VISION, INC.'s specialty is Point of Service.
What type of doctor is OPTIQUS VISION, INC.?
OPTIQUS VISION, INC. is a Point of Service.
Is OPTIQUS VISION, INC. a Point of Service?
Yes, OPTIQUS VISION, INC. is a Point of Service.
Is OPTIQUS VISION, INC. still practicing?
Yes, OPTIQUS VISION, INC. is currently practicing.
Is OPTIQUS VISION, INC. accepting new patients?
OPTIQUS VISION, INC. may be accepting new patients. Please call their office at (787) 272-7777 to inquire about availability.
Is NPI 1255734554 still active?
Yes, NPI 1255734554 is currently active.
Where does OPTIQUS VISION, INC. practice?
OPTIQUS VISION, INC. practices in GUAYNABO, PR.